Home
Conditions
Advanced Melanoma

Clinical trial condition

Advanced Melanoma

Explore clinical trials studying Advanced Melanoma. Study availability and eligibility vary by location and protocol.

67 public trials 22 recruiting studies

Refine in advanced search Browse all conditions

Advanced Melanoma trial results

Recruiting

High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial

NCT06298734

Conditions: Advanced Melanoma, Melanoma, Melanoma (Skin), +12 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

A Clinical Study of T3011 in Subjects With Advanced Melanoma

NCT06214156

Conditions: Advanced Melanoma
Locations: Beijing Cancer Hospital Beijing, China

The First Affiliated Hospital of Bengbu Medical College Bengbu, China

Jilin Cancer Hospital Changchun, China

Chengdu Shangjin Nanfu Hospital Chengdu, China

View Trial Details

Recruiting

Sitagliptin With Pembro in RCC and Melanoma

NCT07634380

Conditions: Advanced Melanoma, Advanced Renal Cell Carcinoma
Locations: University of Iowa Iowa City, Iowa, United States

View Trial Details

Recruiting

Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors

NCT05629546

Conditions: Advanced Melanoma, Melanoma, Metastatic Melanoma, +11 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Recruiting

VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]

NCT06264180

Conditions: Advanced Melanoma
Locations: Banner MD Anderson Cancer Center Gilbert, Arizona, United States

UC San Diego Moores Cancer Center La Jolla, California, United States

The Angeles Clinic and Research Institute Los Angeles, California, United States

USC Norris Comprehensive Cancer Center Los Angeles, California, United States

View all 81 locations

View Trial Details

Recruiting

AB821 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

NCT07027488

Conditions: Advanced Melanoma, Advanced Melanoma and Normal or Impaired
Locations: Yale University New Haven, Connecticut, United States

View Trial Details

Recruiting

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

NCT07405086

Conditions: Adenocarcinoma, Advanced Biliary Tract Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, +63 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Recruiting

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

NCT05039801

Conditions: Adnexal Diseases, Advanced Endometrial Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, +71 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

A Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients With Advanced Melanoma

NCT07099430

Conditions: Advanced Melanoma
Locations: Fujian Cancer Hospital Fuzhou, Fujian, China

Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

Dermatology Hospital of Southern Medical University Guangzhou, Guangdong, China

Guangxi Medical University Cancer Hospital Nanning, Guangxi, China

View all 15 locations

View Trial Details

Recruiting

NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma

NCT06889766

Conditions: Advanced Melanoma, Melanoma, Melanoma Metastatic, +13 more
Locations: Centre Hospitalier Universitaire Vaudois (CHUV) Lausanne, Canton of Vaud, Switzerland

Centre Hospitalier Universitaire Vaudois Lausanne, Canton of Vaud, Switzerland

View Trial Details

Advanced Melanoma

Advanced Melanoma trial results

Related conditions